文献速递胸部腹部技术与安全CT

基于体重指数和临床指征的成人胸部与腹部CT检查本地临床诊断参考水平:一项前瞻性多中心研究

Local clinical diagnostic reference levels for chest and abdomen CT examinations in adults as a function of body mass index and clinical indication: a prospective multicenter study.
PubMed 文献 · Eur Radiol · 2019-05-29

该前瞻性多中心研究在瑞士5台CT设备上收集了5310例腹部和1058例胸部CT序列,按临床指征和BMI分类(<25;≥25)优化协议后,将基于临床指征的机构剂量水平与基于解剖部位的国家诊断参考水平(NDRLs)比较,并估算本地临床诊断参考水平(LCDRLs)。结果显示胸部检查剂量指标多低于NDRLs第75百分位,腹部检查显著低于或相当于第50百分位;LCDRLs较当前DRLs平均下降胸部CTDIvol 21%、腹部32%。结论提示基于临床指征的DRLs的必要性,按BMI分层可进一步优化CT剂量。

要点

  • 基于临床指征的剂量水平在多数情况下低于基于解剖部位的NDRLs,提示前者可能更合适。
  • 按BMI分层(<25 vs ≥25)可进一步优化CT剂量并设定基于BMI分层的LCDRLs。
  • 腹部检查中肾肿瘤的LCDRL差异最大:BMI<25为4.6 mGy vs BMI≥25为10.0 mGy(-117%)。

核心结论

  • 结果提示估算基于临床指征的DRLs是必要的,尤其是腹部检查;按BMI分层可进一步优化CT剂量。

研究设计与样本

  • 前瞻性多中心研究,2017年2月至2018年6月期间,在瑞士一个多中心集团的5台CT设备上,按临床指征和BMI分类(<25;≥25)优化协议后,收集了5310例腹部和1058例胸部CT序列;将基于临床指征的机构剂量水平与瑞士基于解剖部位的NDRLs比较,统计显著性设定为p<0.05;LCDRLs计算为每台CT设备中位剂量值的第三四分位数。

诊断标准与关键数值

  • 胸部检查:基于临床指征的CTDIvol范围3.9-6.4 mGy,低于NDRLs第75百分位7.0 mGy;DLP范围164.0-211.2 mGycm,低于NDRLs第75百分位250 mGycm,但BMI≥25组的DLP为248.8-255.4 mGycm,与NDRLs第75百分位250.0 mGycm相比未明确低于。
  • 腹部检查:基于临床指征的剂量指标在所有BMI分类中显著低于或与NDRLs第50百分位无差异(CTDIvol 3.8-9.0 mGy vs 10.0 mGy;DLP 192.9-446.8 mGycm vs 470 mGycm)。
  • 估算的LCDRLs较当前DRLs平均下降:胸部CTDIvol下降21%,腹部CTDIvol下降32%。
  • 同一临床指征内BMI分层最大LCDRL差异为肾肿瘤:BMI<25组4.6 mGy vs BMI≥25组10.0 mGy(-117%)。

临床应用与阅片要点

  • 作者认为基于临床指征的DRLs可能比基于解剖部位的DRLs更合适,并可能有助于减少同类检查中剂量水平的大幅波动。
  • 按患者体型亚组(非超重、超重)分层数据可更好地优化CT剂量,从而有可能基于BMI分类设定LCDRLs。
  • 作者建议促进持续剂量优化和LDRLs的机构应考虑基于临床指征和BMI分组定义协议,以实现ALARA。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare institutional dose levels based on clinical indication and BMI class to anatomy-based national DRLs (NDRLs) in chest and abdomen CT examinations and to assess local clinical diagnostic reference levels (LCDRLs).

METHODS: From February 2017 to June 2018, after protocol optimization according to clinical indication and body mass index (BMI) class (< 25; ≥ 25), 5310 abdomen and 1058 chest CT series were collected from 5 CT scanners in a Swiss multicenter group. Clinical indication-based institutional dose levels were compared to the Swiss anatomy-based NDRLs. Statistical significance was assessed (p < 0.05). LCDRLs were calculated as the third quartile of the median dose values for each CT scanner.

RESULTS: For chest examinations, dose metrics based on clinical indication were always below P75 NDRL for CTDIvol (range 3.9-6.4 vs. 7.0 mGy) and DLP (164.0-211.2 vs. 250 mGycm) in all BMI classes except for DLP in BMI ≥ 25 (248.8-255.4 vs. 250.0 mGycm). For abdomen examinations, they were significantly lower or not different than P50 NDRLs for all BMI classes (3.8-9.0 vs. 10.0 mGy and 192.9-446.8 vs. 470mGycm). The estimated LCDRLs show a drop in CTDIvol (21% for chest and 32% for abdomen, on average) with respect to current DRLs. When considering BMI stratification, the largest LCDRL difference within the same clinical indication is for renal tumor (4.6 mGy for BMI < 25 vs. 10.0 mGy for BMI ≥ 25; - 117%).

CONCLUSION: The results suggest the necessity of estimating clinical indication-based DRLs, especially for abdomen examinations. Stratifying per BMI class allows further optimization of the CT doses.

KEY POINTS: • Our data show that clinical indication-based DRLs might be more appropriate than anatomy-based DRLs and might help in reducing large variations in dose levels for the same type of examinations. • Stratifying the data per patient-size subgroups (non-overweight, overweight) allows a better optimization of CT doses and therefore the possibility to set LCDRLs based on BMI class. • Institutions who are fostering continuous dose optimization and LDRLs should consider defining protocols based on clinical indication and BMI group, to achieve ALARA.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Brat H, Zanca F, Montandon S, et al. Local clinical diagnostic reference levels for chest and abdomen CT examinations in adults as a function of body mass index and clinical indication: a prospective multicenter study. Eur Radiol. 2019. PMID: 31144074. doi:10.1007/s00330-019-06257-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。